Canton Hathaway, LLC Biogen Inc. Transaction History

Canton Hathaway, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$268.85 - $341.04 $134,425 - $170,520	-500 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$220.06 - $304.07 $110,030 - $152,035	500 New	500 $148,000
Q3 2019 Oct 11, 2019	SELL	$217.44 - $243.88 $3,261 - $3,658	-15 Closed	0 $0
Q2 2019 Jul 15, 2019	SELL	$219.29 - $241.72 $9,868 - $10,877	-45 Reduced 75.0%	15 $4,000
Q1 2019 Apr 10, 2019	BUY	$216.71 - $338.96 $13,002 - $20,337	60 New	60 $14,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

Stay updated on Canton Hathaway, LLC with notifications on news.